About 80 entries were shortlisted in the pharma category at Lions Health creativity festival, including 19 entries from US agencies.
The awards will be announced later today at the second annual Lions Health, a two-day event that kicks off today in advance of the Cannes Lions festival.
Agencies are closely watching the pharma category after last year's jury declined to award a Grand Prix, the event's top prize, to a pharma entry, which raised broader questions about creativity within the pharmaceutical sector.
Of the US shortlisted entries, there are some surprising clients, including Quest Diagnostics, one of the nation's largest laboratory services providers, and Microsoft OneNote. But a number of entries for traditional Big Pharma companies were also shortlisted, including Novartis Vaccines, AbbVie's blockbuster rheumatoid arthritis drug Humira and GlaxoSmithKline's Anoro Ellipta, a new treatment for chronic obstructive pulmonary disease.
DigitasLBI in New York is only US agency to have three entries shortlisted for AstraZeneca's disease-education campaign “Take it from a Fish,” which includes integrated digital campaign, digital and direct and promotional and activation. AstraZeneca received FDA approval last year for Epanova, a prescription fish-oil pill.
Possible Seattle and CDM in New York each had two shortlisted entries.
Other US agencies with a shortlisted entry are: McCann Echo (Mountain Lakes), StrawberryFrog (New York), CDM (New York), GSW (Columbus, Ohio), Aeras (Rockville, Md.), Ruder Finn (New York), Publicis Kaplan Thaler (New York), Havas Worldwide Tonic (New York), CDMiConnect, Alma DDB (Miami), Hill Holliday (Boston) and Deutsch (New York).
In the health and wellness category, there are 180 shortlisted entries, with 15 entries from US agencies